Safer sleep for mom, safer start for baby? anesthesia study aims to protect premature newborns
NCT ID NCT02029898
Summary
This study looked at whether using a specific, short-acting pain medication (remifentanil) for mothers during emergency C-sections for premature births is safe for the baby's first critical minutes. Researchers compared babies whose mothers received this medication to those whose mothers did not, focusing on the baby's breathing, heart rate, and overall condition right after birth. The goal was to find the best way to manage the mother's pain while minimizing any potential risks to the fragile newborn.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Rouen
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.